Maze Therapeutics (MAZE) Other Non-Current Assets (2024 - 2026)

Maze Therapeutics' Other Non-Current Assets history runs 3 years deep, the most recent figure standing at $1.1 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets rose 1.01% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $1.1 million (up 1.01% YoY), while the FY2025 annual figure was $3.0 million, down 61.25% from the prior year.
• Other Non-Current Assets came in at $1.1 million for Q1 2026 at Maze Therapeutics, down from $3.0 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $7.9 million in Q4 2024 to a low of $1.1 million in Q1 2025.
• A 3-year average of $2.5 million and a median of $1.1 million in 2025 frame the typical range for Other Non-Current Assets.
• Across the five-year window, Other Non-Current Assets sank 61.25% in 2025 and grew 1.01% in 2026, its largest moves.
• Maze Therapeutics' Other Non-Current Assets stood at $7.9 million in 2024, then tumbled by 61.25% to $3.0 million in 2025, then tumbled by 63.91% to $1.1 million in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $1.1 million, $3.0 million, and $1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison